tiprankstipranks
ImmunityBio (IBRX)
NASDAQ:IBRX
Holding IBRX?
Track your performance easily

ImmunityBio (IBRX) Cash flow

1,162 Followers

ImmunityBio Cash Flow

IBRX's free cash flow for Q3 2024 was $-101.56M. For the 2024 fiscal year, IBRX's free cash flow was decreased by $39.56M and operating cash flow was $-98.76M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -421.36M$ -366.76M$ -337.51M$ -274.42M$ -171.72M
Investing Cash Flow
$ -19.83M$ -30.47M$ 27.30M$ -84.89M$ -19.81M
Financing Cash Flow
$ 375.24M$ 558.34M$ 233.61M$ 505.44M$ 150.68M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 480.41M$ 104.64M$ 104.64M$ 181.10M$ 34.91M
Income Tax Paid Supplemental Data
$ 23.00K$ 8.00K$ 2.00K$ 9.00K$ 8.00K
Interest Paid Supplemental Data
$ 115.74M$ 77.19M$ 35.44M$ 2.11M$ 40.00K
Issuance Of Capital Stock
--$ 60.43M$ 164.53M$ 86.30M
Issuance Of Debt
$ 289.64M$ 451.39M$ 174.07M$ 338.50M$ 63.70M
Repayment Of Debt
$ -84.00K$ -77.00K$ -58.00K--
Free Cash Flow
$ -434.10M$ -397.34M$ -436.90M$ -287.48M$ -173.39M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

ImmunityBio Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis